WAGNER CHARLES F JR — SEC Form 4 filings
SEC reporting owner CIK 1223348. 24 Form 4 filings on record with FilingPulse; latest filed 2026-06-11.
Transaction summary — filings shown
Covers all 24 filings on record, filed 2024-02-08 to 2026-06-11. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 7 legs across 6 filings — 36,330 shares, $16,955,130 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 35.
- Largest priced transaction: sale of 9,532 shares @ $461.00 ($4,394,252) in VERTEX PHARMACEUTICALS INC / MA, filed 2026-01-08.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP, CO & FO | 21 | — | 7 legs · 36,330 sh · $16,955,130 | 23 |
| TJX COMPANIES INC /DE/ (TJX) | Director | 3 | — | — | 12 |
Form 4 filings — WAGNER CHARLES F JR
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-11 | 4 | TJX COMPANIES INC /DE/ (TJX) | Grant/award (A): 636.87 (derivative) @ $0 · Grant/award (A): 26.50 (derivative) @ $0 · Grant/award (A): 636.87 (derivative) @ $0 · Grant/award (A): 26.50 (derivative) @ $0 | EDGAR |
| 2026-02-26 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Tax withholding (F): 1,744 @ $485.11 | EDGAR |
| 2026-02-19 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Grant/award (A): 7,365 @ $0 · Tax withholding (F): 2,294 @ $483.75 | EDGAR |
| 2026-02-18 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Tax withholding (F): 4,565 @ $487.76 | EDGAR |
| 2026-02-12 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Tax withholding (F): 3,045 @ $468.41 | EDGAR |
| 2026-01-26 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Grant/award (A): 9,440 @ $0 · Grant/award (A): 4,160 @ $0 | EDGAR |
| 2026-01-08 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Option exercise (M): 9,532 @ $189.38 · Sale (S): 9,532 @ $461 · Option exercise (M): 9,532 (derivative) @ $0 | EDGAR |
| 2025-12-05 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Sale (S): 7,000 @ $451 · Sale (S): 7,000 @ $461 | EDGAR |
| 2025-06-12 | 4 | TJX COMPANIES INC /DE/ (TJX) | Grant/award (A): 793.40 (derivative) @ $0 · Grant/award (A): 20.60 (derivative) @ $0 · Grant/award (A): 793.40 (derivative) @ $0 · Grant/award (A): 20.60 (derivative) @ $0 | EDGAR |
| 2025-03-12 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Sale (S): 3,298 @ $500 | EDGAR |
| 2025-02-28 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Tax withholding (F): 4,962 @ $479.61 | EDGAR |
| 2025-02-26 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Tax withholding (F): 3,310 @ $483.28 | EDGAR |
| 2025-02-19 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Tax withholding (F): 2,293 @ $463.46 | EDGAR |
| 2025-02-14 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Grant/award (A): 6,655 @ $0 | EDGAR |
| 2025-02-12 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Tax withholding (F): 2,649 @ $467.98 | EDGAR |
| 2025-02-06 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Grant/award (A): 10,262 @ $0 · Grant/award (A): 7,114 @ $0 | EDGAR |
| 2024-11-13 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Sale (S): 3,000 @ $518.27 | EDGAR |
| 2024-06-06 | 4 | TJX COMPANIES INC /DE/ (TJX) | Grant/award (A): 944.55 (derivative) @ $0 · Grant/award (A): 9.35 (derivative) @ $0 · Grant/award (A): 944.55 (derivative) @ $0 · Grant/award (A): 9.35 (derivative) @ $0 | EDGAR |
| 2024-06-05 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Sale (S): 3,250 @ $460 | EDGAR |
| 2024-05-30 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Sale (S): 3,250 @ $454.79 | EDGAR |
| 2024-02-27 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Tax withholding (F): 3,309 @ $431.79 | EDGAR |
| 2024-02-21 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Tax withholding (F): 3,750 @ $424.01 · Tax withholding (F): 2,812 @ $420.58 | EDGAR |
| 2024-02-13 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Tax withholding (F): 2,607 @ $422.74 | EDGAR |
| 2024-02-08 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Grant/award (A): 5,814 @ $0 · Grant/award (A): 9,440 @ $0 · Grant/award (A): 7,114 @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1223348 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →